J6M-MC-JSGD A Phase 2 Randomized Open-Label Dose Optimization and Phase 3 Randomized Double-Blind Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+ HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2). this is the text in CTMS but then in florence appears like this
